Skip to Main Content

Paper Details

Preclinical evaluation of the selective small-molecule UBA1 inhibitor, TAK-243, in acute myeloid leukemia.
Leukemia
52
2019
Author NameAffiliation
Parasvi S PatelPrincess Margaret Cancer Centre, University Health Network
Parasvi S PatelUniversity of Toronto
Marcela GrondaPrincess Margaret Cancer Centre, University Health Network
Rose HurrenPrincess Margaret Cancer Centre, University Health Network
Razqallah HakemPrincess Margaret Cancer Centre, University Health Network
Razqallah HakemUniversity of Toronto
Aaron D SchimmerPrincess Margaret Cancer Centre, University Health Network
Aaron D SchimmerUniversity of Toronto
  • 1 - 8

Datasets

Release 1.2